![Richard Dee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Dee
Keine laufenden Positionen mehr
Profil
Mr. Richard Dee is on the Board of Directors at Critical Care Diagnostics, Inc.
He received his undergraduate degree from the University of British Columbia and an MBA from the University of Pennsylvania.
Ehemalige bekannte Positionen von Richard Dee
Unternehmen | Position | Ende |
---|---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Richard Dee
University of Pennsylvania | Masters Business Admin |
University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |